Cargando…

Prognostic significance of esterase gene expression in multiple myeloma

BACKGROUND: Esterase enzymes differ in substrate specificity and biological function and may display dysregulated expression in cancer. This study evaluated the biological significance of esterase expression in multiple myeloma (MM). METHODS: For gene expression profiling and evaluation of genomic v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumari, Romika, Majumder, Muntasir Mamun, Lievonen, Juha, Silvennoinen, Raija, Anttila, Pekka, Nupponen, Nina N., Lehmann, Fredrik, Heckman, Caroline A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039029/ https://www.ncbi.nlm.nih.gov/pubmed/33531688 http://dx.doi.org/10.1038/s41416-020-01237-1

Ejemplares similares

Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen
por: Miettinen, Juho J., et al.
Publicado: (2021)

S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma
por: Liu, Minxia, et al.
Publicado: (2021)

Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing
por: Majumder, Muntasir Mamun, et al.
Publicado: (2017)

A germline exome analysis reveals harmful POT1 variants in multiple myeloma patients and families
por: Hakkarainen, Marja, et al.
Publicado: (2022)

Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients
por: Tierney, Ciara, et al.
Publicado: (2021)

The Peptide–Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell Death
por: Flanagan, Ken, et al.
Publicado: (2022)

Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005–2016
por: Toppila, Iiro, et al.
Publicado: (2022)

Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy
por: Luoma, Sini, et al.
Publicado: (2023)

PB2071: SENSITIVITY OF MULTIPLE MYELOMA TO MELFLUFEN ASSOCIATES WITH DECREASED P53 ACTIVITY AND ENRICHMENT OF DNA DAMAGE REPAIR PATHWAY GENES
por: Miettinen, Juho, et al.
Publicado: (2023)

RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group
por: Luoma, Sini, et al.
Publicado: (2019)

The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains
por: Alzrigat, Mohammad, et al.
Publicado: (2017)

Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen
por: Gebraad, Arjen, et al.
Publicado: (2022)

Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer
por: Malyutina, Alina, et al.
Publicado: (2019)

Multiple Myeloma: Relationship to Antioxidant Esterases
por: Ellidag, Hamit Yasar, et al.
Publicado: (2013)

Mobilization Strategies in Myeloma Patients Intended for Autologous Hematopoietic Cell Transplantation
por: Jantunen, Esa, et al.
Publicado: (2023)

Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013
por: Remes, Kari, et al.
Publicado: (2018)

On The Physiological Significance of Choline Esterase
por: Nachmansohn, D.
Publicado: (1940)

Real‐world experience of novel multiple myeloma treatments in a large, single‐center cohort in Finland
por: Loponen, Heidi, et al.
Publicado: (2023)

Improving genomics-based predictions for precision medicine through active elicitation of expert knowledge
por: Sundin, Iiris, et al.
Publicado: (2018)

Prognostic significance of methyl-p-hydroxy-phenyllactate-esterase activity in laryngeal squamous cell carcinoma.
por: Maurizi, M., et al.
Publicado: (1998)

Long-term outcome after allogeneic stem cell transplantation in multiple myeloma
por: Luoma, Sini, et al.
Publicado: (2021)

Prognostic significance of FSCN family in multiple myeloma
por: Deng, Cong, et al.
Publicado: (2021)

P874: DECIPHERING PLASMA CELL HETEROGENEITY AND TUMOR MICROENVIRONMENT IN LIGHT-CHAIN AMYLOIDOSIS USING SINGLE CELL RNA-SEQUENCING
por: Srivastava, A., et al.
Publicado: (2022)

P898: A PROSPECTIVE PHASE 2 STUDY TO ASSESS MINIMAL RESIDUAL DISEASE AFTER IXAZOMIB, LENALIDOMIDE, DEXAMETHASONE (IRD) TREATMENT FOR NEWLY DIAGNOSED TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS
por: Silvennoinen, Raija, et al.
Publicado: (2023)

Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma
por: Binder, M, et al.
Publicado: (2016)

Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies
por: Yadav, Bhagwan, et al.
Publicado: (2014)

Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma
por: Silvennoinen, R, et al.
Publicado: (2014)

Effects and Management of Parthenium hysterophorus: A Weed of Global Significance
por: Kaur, Manpreet, et al.
Publicado: (2014)

Prediction and prognostic significance of BCAR3 expression in patients with multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2018)

Homologous recombination repairs secondary replication induced DNA double-strand breaks after ionizing radiation
por: Groth, Petra, et al.
Publicado: (2012)

Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinoma.
por: Janssen, C. W., et al.
Publicado: (1989)

Quantitative online survey of self-perceived knowledge and knowledge gaps of medicines research and development among Finnish general public
por: Tran Minh, Mirjami, et al.
Publicado: (2022)

Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance
por: Wang, Gang, et al.
Publicado: (2019)

Prognostic significance of thromboembolism in multiple myeloma: a systematic review and meta-analysis
por: An, Na, et al.
Publicado: (2023)

The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients
por: Yao, Weiqin, et al.
Publicado: (2023)

DISTRIBUTION OF ESTERASE IN GASTRIC MUCOSA
por: Doyle, W. L.
Publicado: (1954)

ESTERASES OF TESTIS AND OTHER TISSUES
por: Huggins, Charles, et al.
Publicado: (1948)

Hyperthermostable acetyl xylan esterase
por: Drzewiecki, Katharina, et al.
Publicado: (2010)

An Overview of Antennal Esterases in Lepidoptera
por: Godoy, Ricardo, et al.
Publicado: (2021)

Immunological and prognostic significance of tumour necrosis in colorectal cancer
por: Kastinen, Meeri, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r113ig7hpbjubqd1ng3kf82331